Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Lockheed Martin to buy Ultra Maritime for $3.45bn

(Sharecast News) - US defence firm Lockheed Martin confirmed on Monday that it has agreed to buy Ultra Maritime from private equity firm Advent for $3.45bn. Ultra Maritime specialises in advanced undersea warfare and anti-submarine warfare (ASW) capabilities for allied naval forces. The company develops and delivers mission-critical systems including sonar technologies, sonobuoys, torpedo defence systems, radar solutions, and autonomous maritime sensing platforms.

Lockheed said Ultra's international footprint and portfolio of exportable ASW products will complement and expand its ability to offer sonar solutions across next-gen maritime platforms.

Stephanie C. Hill, president of Lockheed Martin Rotary and Mission Systems, said: "Undersea superiority belongs to those who move fastest and work together best.

"By joining forces with Ultra Maritime, we're accelerating our commitment to deliver the most advanced undersea and anti-submarine warfare capabilities to our US and allied partners across the globe."

Shonnel Malani, managing partner at Advent and chair of the board at Ultra Electronics, said: "When we invested in Ultra Maritime in 2022, we saw a business with mission-critical technology and a vital role in protecting allied nations from undersea threats, but one that had been underinvested and was not yet fully delivering for its customers.

"Over the past four years, we have changed that. Ultra Maritime is now a stronger, more innovative partner to allied navies, with improved execution, greater industrial capacity and next-generation autonomous solutions that position it well for future warfare."

Share this article

Related Sharecast Articles

Future exploring sale of B2B division
(Sharecast News) - Go Compare owner Future confirmed on Friday that it is exploring strategic options regarding its business-to-business division.
Berenberg raises target price on Persimmon, keeps 'hold' rating
(Sharecast News) - Analysts at Berenberg raised their target price on housebuilder Persimmon from 1,150p to 1,240p on Friday after lifting their 2026-27 earnings per share estimates by an average of 2% following the group's third-quarter trading update.
Wise H1 profits climb as customer base tops 16m
(Sharecast News) - Global fintech group Wise reported a jump in first-half revenue and profits on Friday, putting the recently dual-listed firm on track to hit the upper end of its full-year growth targets.
GSK wins positive CHMP opinion for Bexsero meningitis B booster
(Sharecast News) - Pharmaceutical giant GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had issued a positive opinion recommending a label update for its Bexsero meningitis B vaccine.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.